Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Rosacea Patients

NCT01134991 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

21

Enrollment

INDUSTRY

Sponsor class

Stopped Difficulty in recruitment

Conditions

Rosacea

Interventions

DRUG: Topical Minocycline Foam FXFM244

Sponsor

Vyne Therapeutics Inc.